Patents by Inventor Markus Kleinewietfeld

Markus Kleinewietfeld has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and kit for rapid isolation of human Foxp3+ Treg cells
    Patent number: 9213028
    Abstract: The present invention relates to methods for isolating human forkhead box P3 (Foxp3+) CD4+ regulatory T cells (herein referred to a Foxp3+ Treg cells) from a sample containing (i) peripheral blood mononuclear cells (PBMCs), (ii) a lymphocyte containing fluid, or (iii) a lymphocyte containing tissue, a kit for isolating human Foxp3+ Treg cells, and the use of anti-CD49d antibody for the isolation of human Foxp3+ Treg cells.
    Type: Grant
    Filed: November 25, 2013
    Date of Patent: December 15, 2015
    Assignee: MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN (MDC)
    Inventors: Olaf Roetzschke, Kirsten Falk, Markus Kleinewietfeld
  • METHOD AND KIT FOR RAPID ISOLATION OF HUMAN FOXP3+ TREG CELLS
    Publication number: 20140080150
    Abstract: The present invention relates to methods for isolating human forkhead box P3 (Foxp3+) CD4+ regulatory T cells (herein referred to a Foxp3+ Treg cells) from a sample containing (i) peripheral blood mononuclear cells (PBMCs), (ii) a lymphocyte containing fluid, or (iii) a lymphocyte containing tissue, a kit for isolating human Foxp3+ Treg cells, and the use of anti-CD49d antibody for the isolation of human Foxp3+ Treg cells.
    Type: Application
    Filed: November 25, 2013
    Publication date: March 20, 2014
    Applicant: Max-Delbruck-Centrum fur Molekulare Medizin (MDC)
    Inventors: Olaf Roetzschke, Kirsten Falk, Markus Kleinewietfeld
  • Method and Kit for Rapid Isolation of Human Foxp3+ Treg Cells
    Publication number: 20110014697
    Abstract: The present invention relates to methods for isolating human forkhead box P3 (Foxp3+) CD4+ regulatory T cells (herein referred to as Foxp3+ Treg cells) from a sample containing (i) peripheral blood mononuclear cells (PBMCs), (ii) a lymphocyte containing fluid, or (iii) a lymphocyte containing tissue, a kit for isolating human Foxp3+ Treg cells, and the use of anti-CD49d antibody for the isolation of human Foxp3+ Treg cells.
    Type: Application
    Filed: October 10, 2008
    Publication date: January 20, 2011
    Inventors: Olaf Roetzschke, Kirsten Falk, Markus Kleinewietfeld